Cargando…
Long-term taxonomic and functional divergence from donor bacterial strains following fecal microbiota transplantation in immunocompromised patients
Immunocompromised individuals are at high risk of developing Clostridium difficile-associated disease (CDAD). Fecal microbiota transplantation (FMT) is a highly effective therapy for refractory or recurrent CDAD and, despite safety concerns, has recently been offered to immunocompromised patients. W...
Autores principales: | Moss, Eli L., Falconer, Shannon B., Tkachenko, Ekaterina, Wang, Mingjie, Systrom, Hannah, Mahabamunuge, Jasmin, Relman, David A., Hohmann, Elizabeth L., Bhatt, Ami S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5565110/ https://www.ncbi.nlm.nih.gov/pubmed/28827811 http://dx.doi.org/10.1371/journal.pone.0182585 |
Ejemplares similares
-
Oral, frozen fecal microbiota transplant (FMT) capsules for recurrent Clostridium difficile infection
por: Youngster, Ilan, et al.
Publicado: (2016) -
Fecal microbiota transplantation for the improvement of metabolism in obesity: The FMT-TRIM double-blind placebo-controlled pilot trial
por: Yu, Elaine W., et al.
Publicado: (2020) -
Variation in Taxonomic Composition of the Fecal Microbiota in an Inbred Mouse Strain across Individuals and Time
por: Hoy, Yana Emmy, et al.
Publicado: (2015) -
OR26-06 Fecal Microbiota Transplantation Trial for the Improvement of Metabolism (FMT-TRIM): A Randomized Double-Blind Placebo-Controlled Pilot Trial
por: Yu, Elaine Wei-Yin, et al.
Publicado: (2020) -
Recurrent Relatively Resistant Salmonella infantis Infection in 2 Immunocompromised Hosts Cleared With Prolonged Antibiotics and Fecal Microbiota Transplantation
por: Torres Soto, Mariam, et al.
Publicado: (2018)